Skip to Main Content
Our Commitment to Diversity


Raphael Bloch

Advised i2a SA, d/b/a i2a Diagnostics, and its three founders in a majority investment by London, England-based private equity fund Apposite Capital. We also advised the founders in their sale of secondary shares. i2a is a provider of instruments, software, and reagents for the clinical microbiology market in France.
Advised French banking group Crédit Mutuel Arkéa in the majority stake acquisition/investment in French silver tech company Creative Specific Software, a designer and distributer of a patented fall detection solution for the elderly and dependent people by AS2D, a joint-venture with Delta Dore. The merger supports Creative Specific Software’s strong development in France, Europe, and the United States.
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel